Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes. | J Cell Mol Med | 2022 | 36380727 | PubTator, text mining | PubMed |
| Expression profile and prognostic values of LSM family in skin cutaneous melanoma. | BMC Med Genomics | 2022 | 36371223 | PubTator, text mining | PubMed |
| Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis. | Cancers (Basel) | 2022 | 36358658 | PubTator, text mining | PubMed |
| LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence. | Cancers (Basel) | 2022 | 36358655 | PubTator, text mining | PubMed |
| NADPH Oxidase 5 (NOX5) Overexpression Promotes Endothelial Dysfunction via Cell Apoptosis, Migration, and Metabolic Alterations in Human Brain Microvascular Endothelial Cells (hCMEC/D3). | Antioxidants (Basel) | 2022 | 36358519 | PubTator, text mining | PubMed |
| An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neurons. | Nat Commun | 2022 | 36357392 | PubTator, text mining | PubMed |
| Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes. | BMC Cancer | 2022 | 36348317 | PubTator, text mining | PubMed |
| Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis. | iScience | 2022 | 36339263 | PubTator, text mining | PubMed |
| Predicting the influence of Circ_0059706 expression on prognosis in patients with acute myeloid leukemia using classical statistics and machine learning. | Front Genet | 2022 | 36338954 | PubTator, text mining | PubMed |
| The genetics of myelodysplastic syndromes and the opportunities for tailored treatments. | Front Oncol | 2022 | 36338673 | PubTator, text mining | PubMed |
| Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases. | Blood Cancer J | 2022 | 36323674 | PubTator, text mining | PubMed |
| One novel ACOT7-NPHP4 fusion gene identified in one patient with acute lymphoblastic leukemia: a case report. | BMC Med Genomics | 2022 | 36316773 | PubTator, text mining | PubMed |
| Development and validation of a novel prognosis prediction model for patients with myelodysplastic syndrome. | Front Oncol | 2022 | 36313674 | PubTator, text mining | PubMed |
| Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19. | Front Immunol | 2022 | 36311800 | PubTator, text mining | PubMed |
| Different Gene Sets Are Associated With Azacitidine Response In Vitro Versus in Myelodysplastic Syndrome Patients. | Hemasphere | 2022 | 36310757 | PubTator, text mining | PubMed |
| RNA binding proteins in MLL-rearranged leukemia. | Exp Hematol Oncol | 2022 | 36307883 | PubTator, text mining | PubMed |
| Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia. | Cold Spring Harb Mol Case Stud | 2022 | 36307214 | PubTator, text mining | PubMed |
| Genome-wide detection of human variants that disrupt intronic branchpoints. | Proc Natl Acad Sci U S A | 2022 | 36306325 | PubTator, text mining | PubMed |
| [Construction and analysis of transcriptome-based hepatolenticular degeneration regulatory network]. | Sheng Wu Gong Cheng Xue Bao | 2022 | 36305413 | PubTator, text mining | PubMed |
| Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. | Int J Mol Sci | 2022 | 36293442 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=38